ACE and systemic sclerosis: The vascular damage may be further aggravated by the overactivation of vasoconstrictor angiotensin II and rapid degradation of vasodilator bradykinin caused by the angiotensin-converting enzyme (ACE) I/D polymorphism, which is particularly frequent in SSc [64].